IBD Highlights
Gian Eugenio Tontini (1), Luisa Spina (1), Luca Pastorelli (1), Germana De Nucci (1), Flaminia Cavallaro (1), Maurizio Vecchi (1,2), Chiara Zanchi (3), Stefano Martelossi (3)
1 U.O. di Gastroenterologia ed Endoscopia Digestiva, IRCCS Policlinico San Donato di san Donato Milanese (MI)2Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano 3Servizio di Gastroenterologia e Nutrizione Pediatrica, IRCCS Materno Infantile Burlo Garofolo di Trieste
Osteopenia and osteoporosis are important complications of inflammatory bowel diseases (iBd), both in adult and pediatric patients. The pathogenesis of bone loss in iBd is complex, multifactorial, and only partly understood. Low body mass index, early disease onset, malnutrition, growth and pubertal delay, high corticosteroid doses and severe active disease are the main risk factor for decreased bone mineral density (BMd). BMd measurement in all iBd patients at diagnosis and during follow-up is crucial as a basis for the appropriate prevention and treatment.